← All trials
NCT07112196
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 28, 2026
- Primary completion
- Dec 31, 2029
- Completion date
- Dec 31, 2030
- First posted
- Aug 8, 2025
- Last posted
- Aug 8, 2025
- Enrollment
- 518
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- CatalYm GmbHLead sponsor
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.